Elicio Therapeutics (ELTX) Treasury Shares (2020 - 2026)

Elicio Therapeutics (ELTX) has reported Treasury Shares for 6 consecutive years, with $150000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Treasury Shares changed 0.0% year-over-year to $150000.0; the trailing twelve-month figure through Jun 2026 stood at $150000.0 (changed 0.0% YoY), and the FY2025 full-year result was $150000.0, changed 0.0% from the prior year.
• Treasury Shares steadied at $150000.0 in Q2 2026 per ELTX's latest filing, from $150000.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $5.0 million in Q4 2022 and bottomed at $14455.0 in Q3 2023.
• Historically, Treasury Shares has averaged $898224.5 across 5 years, with a median of $14455.0 in 2023.
• The widest YoY moves for Treasury Shares: up 0.0% in 2024, down 0.0% in 2024.
• Over 4 years, Treasury Shares stood at $150000.0 in 2023, then changed by 0.0% to $150000.0 in 2024, then changed by 0.0% to $150000.0 in 2025, then changed by 0.0% to $150000.0 in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $150000.0, $150000.0, and $150000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.